thiotepa has been researched along with Lupus Erythematosus, Systemic in 3 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Langkilde, M | 1 |
| Rossel, I | 1 |
| Deicher, H | 2 |
| Fricke, R | 2 |
| Krull, P | 1 |
| Kruli, P | 1 |
1 review available for thiotepa and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
[Treatment of chronic diseases of connective tissue by cytostatic drugs].
Topics: Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Collagen Diseases; Cyclophosphamide; Female; Huma | 1970 |
2 other studies available for thiotepa and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Intra-articular use of cytostatica. (Thio-Tepa, Azetepa and Osmium acid).
Topics: Adolescent; Adult; Aged; Alkylating Agents; Arthritis, Rheumatoid; Aziridines; Azirines; Female; Hum | 1967 |
[Treatment of chronic connective tissue diseases with cytostatics].
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Chronic Disease; Collagen | 1970 |